Toghrul Sadikhov

Mr. Toghrul Sadikhov

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2025 in Frontiers in Nanotechnology
Verified
Journal Article
Open access
PDF file
AKAynura Karimova
Aynura Karimova
SHSabina Hajizada
Sabina Hajizada
HSHabiba Shirinova
Habiba Shirinova
SNSevinj Nuriyeva
Sevinj Nuriyeva
LGLala Gahramanli
Lala Gahramanli
VYVugar Yagublu
Vugar Yagublu
Introduction: This study focuses on the development of dextran-coated iron oxide nanoparticles (Fe3O4@Dextran NPs) as carriers for chrysin, a natural flavonoid with recognized anticancer activity.Methods: Fe3O4@Dextran NPs were synthesized via co-precipitation and loaded with chrysin at different drug-to-nanoparticle ratios. Structural and physicochemical characterization was performed using X-ray Diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR), and Vibrating Sample Magnetometry (VSM). Drug loading efficiency was determined spectrophotometrically. The anticancer efficacy of the drug-loaded samples was assessed in vitro against HCT-116 human colorectal carcinoma cells using the MTT assay, with statistical analysis performed by one-way ANOVA.Results: XRD revealed an average crystallite size of 17 nm for Fe3O4@Dextran, which decreased to ∼15 nm upon chrysin loading. FTIR confirmed the successful incorporation of chrysin without compromising structural stability. VSM measurements demonstrated superparamagnetic behavior with a saturation magnetization of 69.2 emu/g. Drug loading efficiencies were 42%, 54%, and 57% at drug-to-nanoparticle ratios of 1:0.5, 1:1, and 1:2, respectively, with evidence of saturation at higher concentrations. The Fe3O4@Dextran+D2 formulation exhibited optimal drug loading, maintaining structural integrity and enhanced cytotoxic activity against HCT-116 cells.Conclusion: Fe3O4@Dextran+D2 demonstrated favorable structural integrity (as evidenced by XRD and FTIR analyses) along with notable anticancer activity against HCT-116 cells. Its performance is attributed to optimal drug loading without surface saturation, supporting its potential as a structurally stable drug delivery system.

9 April 2026 in Cancers
Verified
Journal Article
Open access
PDF file
AKAynura Hidayat Karimova
Aynura Hidayat Karimova
HSHabiba Shirinova
Habiba Shirinova
TSToghrul Sadikhov
Toghrul Sadikhov
JHJavahir Hajibabazade
Javahir Hajibabazade
SHSabina Hajizada
Sabina Hajizada
VYVugar Yagublu
Vugar Yagublu
Iron oxide nanoparticles have emerged as multifunctional compounds with prominent potential in cancer theranostics, particularly in photothermal therapy (PTT) and photodynamic therapy (PDT). Their unique electronic and crystal structures, such as the dispersion of Fe2+ and Fe3+ ions and d-orbital splitting, contribute to their magnetic and catalytic properties. In PTT, Fe3O4 nanoparticles exhibit moderate near-infrared (NIR) absorption and photothermal conversion efficiency, which can be enhanced through adjustments in particle size, surface modification, and combinations with other components. In PDT, Fe3O4 nanoparticles demonstrate intrinsic peroxidase-like catalytic activity, facilitating Fenton and photo-Fenton reactions that generate reactive oxygen species (ROS), including hydroxyl radicals (•OH), thereby amplifying oxidative stress in cancer cells. These nanoparticles can also function as carriers for photosensitisers (PS), promoting targeted delivery and enhanced ROS generation. Multifunctional nanomaterials that integrate Fe3O4 with other therapeutic agents and targeting ligands have demonstrated synergistic antitumour effects through amplified photothermal, photodynamic, chemodynamic, and chemotherapeutic mechanisms. Despite certain drawbacks, such as relatively low NIR absorption and challenges in optimising delivery and light activation, ongoing improvements in Fe3O4-based nanoplatforms present significant potential for enhancing treatment outcomes and the precision of cancer therapy. This article systematically explores the synergistic role of Fe3O4 nanoparticles in PTT and PDT, encompassing their magnetic and catalytic characteristics. Additionally, it focuses on multifunctional hybrid nanoplatforms that combine Fe3O4 with targeting or imaging agents, highlighting their potential to enhance therapeutic precision.

5 September 2025 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
TSToghrul Sadikhov
Toghrul Sadikhov
AAAdil Allahverdiyev
Adil Allahverdiyev
NANAZLI Arda
NAZLI Arda